Efficacy and Safety of Itopride vs Placebo in Heartburn

NCT00382577 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2017-02-09

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effects of itopride in patients with heartburn.

Conditions

  • Heartburn

Interventions

DRUG

Itopride

DRUG

Placebo

Sponsors & Collaborators

  • Forest Laboratories

    lead INDUSTRY

Principal Investigators

  • Philip, Jr. B. Miner, M.D. · The Oklahoma Foundation for Digestive Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Completion
2006-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00382577 on ClinicalTrials.gov